Deep-brain stimulation for Parkinson's disease.

Deep-brain stimulation for Parkinson's disease. N Engl J Med (2013) 0.89

Deep-brain stimulation for Parkinson's disease. N Engl J Med (2012) 4.18

Nuclear medicine asleep in sleep research? Eur J Nucl Med Mol Imaging (2002) 1.45

[Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy]. Med Klin (Munich) (2003) 1.40

Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life. Epilepsia (2004) 1.12

Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia (2002) 1.11

Functional imaging: where is the future? Hell J Nucl Med (2005) 1.06

Renal toxicity after radionuclide therapy. Radiat Res (2004) 0.93

Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150. Eur J Nucl Med Mol Imaging (2003) 0.89

Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy. J Clin Sleep Med (2007) 0.84

Imaging of mild traumatic brain injury using 57Co and 99mTc HMPAO SPECT as compared to other diagnostic procedures. Med Sci Monit (2003) 0.82

Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? Eur J Nucl Med Mol Imaging (2002) 0.81

Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers. Eur J Nucl Med Mol Imaging (2003) 0.79

Did Maurice Ravel have a whiplash syndrome? Med Sci Monit (2003) 0.77

Is radiation nephropathy caused by yttrium-90? Lancet (2002) 0.77

Functional neuroimaging endpoints in drug development. Nucl Med Commun (2005) 0.76

Soft tissue metastasis of an osteosarcoma of the humerus in a four-legged patient. Eur J Nucl Med Mol Imaging (2002) 0.76

90Y-Ibritumomab tiuxetan: new drug, interesting concept, and encouraging in practice. Nucl Med Commun (2006) 0.76

Cognitive neuroactivation using SPECT and the Stroop Colored Word Test in patients with diffuse brain injury. J Neurotrauma (2004) 0.76

The whiplash odyssey. Med Sci Monit (2003) 0.75

Non-ionizing diagnostic evaluation of ingested foreign bodies. Dtsch Arztebl Int (2013) 0.75

Positron emission tomography and single-photon emission tomography in neurosciences. Hell J Nucl Med (2012) 0.75

Music and Neurophysiology. Dtsch Arztebl Int (2017) 0.75

Functional imaging of the suicidal brain. Nucl Med Commun (2005) 0.75

90Y-DOTATOC and nephrotoxicity. Eur J Nucl Med Mol Imaging (2002) 0.75

Music and medical research. Med Sci Monit (2004) 0.75

Brain SPECT in sleep research. Sleep (2003) 0.75

The future of nuclear medicine. Hell J Nucl Med (2005) 0.75

Inspiration-sleep-rest and nuclear medicine. Hell J Nucl Med (2006) 0.75

Hybrid imaging: which road to go? Hell J Nucl Med (2008) 0.75

Functional neuroimaging in whiplash injury. Eur J Pain (2012) 0.75

[[Medico-historical findings of (neuro-) prosthetics: an online survey]. Arch Kriminol (2015) 0.75

The rationale of a longer life span and nuclear medicine. Hell J Nucl Med (2011) 0.75

European regulatory framework on the use and development of pharmaceuticals and radiopharmaceuticals for pediatrics. Hell J Nucl Med (2011) 0.75

How diseases become sicker. Med Sci Monit (2002) 0.75

Myelosuppressive side-effects of radioimmunotherapy of non-Hodgkin's lymphoma: is there an increased risk? Nucl Med Commun (2005) 0.75

[Nicolò Paganini: Devil's violinist because of abnormal hands?--New investigations using a bronze cast from the right hand]. Arch Kriminol (2014) 0.75

[Use of sonography in splinter injuries: a model simulation]. Arch Kriminol (2015) 0.75

Whiplash Syndrome- a disorder of the brain? Hell J Nucl Med (2017) 0.75

Functional neuroimaging at the 2002 APSS 16th annual meeting in Seattle. Med Sci Monit (2002) 0.75

Neuroimaging in mild traumatic brain injury and M. Ravel's injury. Hell J Nucl Med (2012) 0.75

The hospital organization of the future. Nucl Med Rev Cent East Eur (2004) 0.75

The legal standards for the radioactive or non radioactive drugs research and approval in the European Community and in Germany after the thalidomide catastrophe. Hell J Nucl Med (2010) 0.75

Practical and clinical benefits of radioimmunotherapy lead to advantages in cost-effectiveness in the treatment of patients with non-Hodgkin's lymphoma. Nucl Med Commun (2006) 0.75

Drug development parameters for functional imaging in neurosciences. Hell J Nucl Med (2007) 0.75

Does health economics have an impact on non-Hodgkin's lymphoma patients' options? Nucl Med Commun (2008) 0.75

Is (90)Y-DOTATOC treatment for neuroendocrine tumours safe? Med Sci Monit (2002) 0.75